A fluorogenic peptide substrate that can be used to monitor 20S Immunoproteasome activity, which is excited at 345 nm and emits at 445 nm. This substrate is specific to the immunoproteasome, and is not hydrolyzed efficiently by the constitutive proteasome.
CAT No: R1032
CAS No:163515-35-3
Synonyms/Alias:Chlorotoxin;163515-35-3;Chlorotoxin TFA;PCN-4282-V;AS-82547;DA-51860;H-DL-Met-DL-Cys(1)-DL-Met-DL-Pro-DL-Cys(2)-DL-Phe-DL-xiThr-DL-xiThr-DL-Asp-DL-His-DL-Gln-DL-Met-DL-Ala-DL-Arg-DL-Lys-DL-Cys(3)-DL-Asp-DL-Asp-DL-Cys(1)-DL-Cys(4)-Gly-Gly-DL-Lys-Gly-DL-Arg-Gly-DL-Lys-DL-Cys(2)-DL-Tyr-Gly-DL-Pro-DL-Gln-DL-Cys(3)-DL-Leu-DL-Cys(4)-DL-Arg-NH2;Met-Cys-Met-Pro-Cys-Phe-Thr-Thr-Asp-His-Gln-Met-Ala-Arg-Lys-Cys-Asp-Asp-Cys-Cys-Gly-Gly-Lys-Gly-Arg-Gly-Lys-Cys-Tyr-Gly-Pro-Gln-Cys- Leu-Cys-Arg-NH2;
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More